Assessment of Pretreatment ABL1 Kinase Domain Mutations in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia
Latest Information Update: 29 Nov 2019
At a glance
- Drugs Dasatinib (Primary) ; Imatinib (Primary) ; Ponatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 29 Nov 2019 New trial record
- 06 Nov 2019 Results released in 61st Annual Meeting and Exposition of the American Society of Hematology.